{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:33:30Z","timestamp":1782257610400,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":1467,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fred Hutchinson Cancer Research Center\/University of Washington Cancer Consortium Cancer Center Support","award":["NCI P01 CA44991"],"award-info":[{"award-number":["NCI P01 CA44991"]}]},{"name":"Fred Hutchinson Cancer Research Center\/University of Washington Cancer Consortium Cancer Center Support","award":["K12 CA076930"],"award-info":[{"award-number":["K12 CA076930"]}]},{"name":"Fred Hutchinson Cancer Research Center\/University of Washington Cancer Consortium Cancer Center Support","award":["K24 CA184039"],"award-info":[{"award-number":["K24 CA184039"]}]},{"name":"Frank and Betty Vandermeer, Don and Debbie Hunkins, the Mary Aileen Wright Memorial Fund, and The David and Patricia Giuliani Family Foundation","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}]},{"name":"Clinical Research of the Leukemia and Lymphoma Society"},{"name":"NIH","award":["5T32 HL007093"],"award-info":[{"award-number":["5T32 HL007093"]}]},{"name":"Fred Hutchinson Cancer Research Center\/University of Washington Cancer Consortium Cancer Center Support","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}]},{"name":"Frank and Betty Vandermeer, Don and Debbie Hunkins, the Mary Aileen Wright Memorial Fund, and The David and Patricia Giuliani Family Foundation"},{"name":"Clinical Research of the Leukemia and Lymphoma Society"},{"name":"NIH","award":["5T32 HL007093"],"award-info":[{"award-number":["5T32 HL007093"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1093\/annonc\/mdv364","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T00:48:35Z","timestamp":1441673315000},"page":"2323-2328","source":"Crossref","is-referenced-by-count":35,"title":["Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma"],"prefix":"10.1016","volume":"26","author":[{"given":"S.A.","family":"Graf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.G.","family":"Till","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.W.","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.","family":"Chauncey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Shustov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"E.N.","family":"Libby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.I.","family":"Bensinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Pagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Cassaday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv364_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.14694\/EdBook_AM.2014.34.191","article-title":"Mantle cell lymphoma: biology, clinical presentation, and therapeutic approaches","author":"Dreyling","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1093\/annonc\/mdv364_bb0015","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2004-10-3883","volume":"105","author":"Dreyling","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv364_bb0020","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","article-title":"Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group","volume":"112","author":"Geisler","year":"2008","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv364_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma","volume":"27","author":"Herrmann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv364_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2011-09-370320","article-title":"CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"121","author":"Delarue","year":"2013","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv364_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2141.2012.09174.x","article-title":"Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur","volume":"158","author":"Geisler","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdv364_bb0040","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2006-04-016725","volume":"108","author":"Forstpointner","year":"2006","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv364_bb0045","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/annonc\/mdl127","article-title":"Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network","volume":"17","author":"Kahl","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv364_bb0050","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.seminhematol.2011.03.008","article-title":"Treatment of elderly patients with mantle cell lymphoma","volume":"48","author":"Kluin-Nelemans","year":"2011","journal-title":"Semin Hematol"},{"key":"10.1093\/annonc\/mdv364_bb0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1200920","article-title":"Treatment of older patients with mantle-cell lymphoma","volume":"367","author":"Kluin-Nelemans","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdv364_bb0060","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/leu.2013.332","article-title":"Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma","volume":"28","author":"Dietrich","year":"2014","journal-title":"Leukemia"},{"issue":"21","key":"10.1093\/annonc\/mdv364_bb0065","volume":"124","author":"Le Gouill","year":"2014"},{"key":"10.1093\/annonc\/mdv364_bb0070","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv364_bb0075","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv364_bb0080","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv364_bb0085","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3324\/haematol.2013.100784","article-title":"Survival analysis in hematologic malignancies: recommendations for clinicians","volume":"99","author":"Delgado","year":"2014","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdv364_bb0090","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdh425","article-title":"Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study","volume":"15","author":"Brugger","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv364_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3816\/CLM.2006.n.051","article-title":"Immunotherapy with rituximab\/interleukin-2 after autologous stem cell transplantation as treatment for CD20+ non-Hodgkin\u2019s lymphoma","volume":"7","author":"Holmberg","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1093\/annonc\/mdv364_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/blood-2003-04-1257","article-title":"Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma","volume":"103","author":"Horwitz","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv364_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/sonc.2002.30143","article-title":"Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma","volume":"29","author":"Mangel","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdv364_bb0110","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2008.21.3116","article-title":"Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma","volume":"27","author":"Andersen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv364_bb0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1179\/1607845414Y.0000000188","article-title":"Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma","volume":"20","author":"Arai","year":"2015","journal-title":"Hematology"},{"key":"10.1093\/annonc\/mdv364_bb0120","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/annonc\/mdq008","article-title":"Clinical impact and predisposing factors of delayed-onset neutropenia after autologous hematopoietic stem-cell transplantation for B-cell non-Hodgkin lymphoma: association with an incremental risk of infectious events","volume":"21","author":"Kato","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv364_bb0125","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.6004\/jnccn.2012.0147","article-title":"Current issues in vaccines for adult patients with hematologic malignancies","volume":"10","author":"Issa","year":"2012","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419363628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419363628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/11\/2323\/16699142\/mdv364.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:55:12Z","timestamp":1624521312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419363628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0923753419363628"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv364","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}